Tag: immuno-oncology

interventional oncology

Interventional Oncology 2.0: Soul-searching to define our identity

Julius Chapiro and Lynn Savic claim there is “no need for scepticism” about the recent emergence and growth of immuno-oncology from an interventional oncologists’...

Surefire Medical appoints Mary T Szela CEO and president

Szela brings nearly 30 years of progressive leadership experience to Surefire building global billion-dollar brands, advancing pipeline products in the biotechnology, medical products, and...
Interventional News for specialists

BTG and SIO expand Immuno-Oncology / Interventional Oncology grant programme

BTG and the Society of Interventional Oncology (SIO) have expanded their commitment to the Immuno-oncology /interventional oncology research grant programme, by announcing a second...

SIO announces first grants in interventional oncology /immuno-oncology research programme

The Society of Interventional Oncology (SIO and BTG have announced their 2017 Interventional interventional oncology /immuno-oncology research grant recipients. The interventional oncology /immuno-oncology research programme...

Interventional oncology should identify “unmet immunotherapy needs”

Daniel Sze, speaking at the ninth annual Symposium on Clinical Interventional Oncology (CIO; 4–5 February 2017, Hollywood, USA), noted that immunotherapy is a “huge...

BTG and SIO to explore role of minimally invasive therapies in...

BTG has announced a collaboration with the Society of Interventional Oncology (SIO; a global organisation working to nurture and support interventional oncology worldwide) to...